[@hubermanlab] How Women Can Improve Their Fertility & Hormone Health | Dr. Natalie Crawford

Link: https://youtu.be/RTPNJgHeZBI

Duration: 156 min

Short Summary

Dr. Natalie Crawford and Dr. Aimee Eyvazzadeh, reproductive endocrinology experts, discuss fertility as a marker of overall health on the Huberman Lab podcast. Fecundability drops dramatically from 20% at age 30 to just 3% by age 40, making proactive testing like AMH ($79 out-of-pocket) critical for understanding reproductive timelines. The guests explain how inflammation, sleep, supplements, and lifestyle factors fundamentally impact fertility outcomes, while challenging the medical field's requirement that patients "fail" for 12 months before testing.

Key Quotes

1. "if you have infertility, you have increased rates of metabolic syndrome, cancer, heart attack, stroke, and dying early" (00:03:54)
2. "you can't make decisions on data you don't know" (00:04:54)
3. "I do not view myself as the gatekeeper of information about your body. Do you want hormone levels checked? Do you want an AMH? I do not think that is the role of a physician" (00:56:10)
4. "doing IVF or egg freezing is not going to decrease your ovarian reserve. It is simply going to influence one month in time trying to not have all those eggs die" (01:40:30)

Detailed Summary

Fertility as an Indicator of Overall Health

The episode emphasizes that fertility serves as a marker of overall hormonal, cellular, and metabolic health rather than simply a reproductive concern. Infertility correlates with increased long-term health risks including metabolic syndrome, cancer, heart attack, stroke, and early death—not because fertility problems cause these conditions, but because they signal underlying chronic inflammation or insulin resistance that affects multiple body systems.

• Women are born with 6–7 million eggs at five months gestation, dropping to 1–2 million at birth and approximately 500,000 by the time of first period
• The correlation between infertility and serious health conditions exists because both stem from shared inflammatory and metabolic pathways
• Fertility problems often emerge before other symptoms of metabolic dysfunction become clinically apparent
• Egg count and quality reflect cellular health, mitochondrial function, and systemic inflammatory burden

Fecundability Decline with Age

The "Time to Conceive" cohort study provides rigorous data on how monthly pregnancy probability changes across the reproductive lifespan. Understanding these statistics helps individuals make informed decisions about when to pursue testing and intervention, particularly for those who may delay family formation.

• A woman's monthly chance of pregnancy (fecundability) is 20% at age 30
• Fecundability drops to 11–12% at ages 35–36
• The decline accelerates to 5% at age 38 and only 3% by age 40
• 72% of people conceive within the first six months of trying; only 13% achieve pregnancy in the subsequent six months
• Women who previously conceived with the same partner maintain 18–20% monthly pregnancy probability up to age 37 before decline accelerates
• These statistics underscore the importance of age when making decisions about fertility preservation

AMH Testing and Ovarian Reserve Assessment

The AMH test provides actionable information about reproductive future, measuring egg quantity rather than quality. At $79 out of pocket, it represents an accessible entry point for understanding reproductive timelines without relying on physician willingness to order testing.

• The AMH test costs $79 out of pocket and can be ordered directly through LabCorp or platforms like Function Health
• Common causes of low AMH include autoimmune disease (found in approximately 50% of cases), insulin resistance, endometriosis, and smoking
• A 30-year-old with 5 eggs and one ovulating has the same per-cycle pregnancy chance as one with 20 eggs, but will retrieve fewer eggs during IVF and enter menopause earlier
• AMH does not predict egg quality, only quantity remaining
• Identifying low ovarian reserve early allows for informed family planning decisions and timeline adjustments
• Testing should ideally occur before attempting conception to establish baseline parameters

Ovulation Mechanics and the Fertile Window

Understanding the precise mechanics of ovulation enables couples to optimize timing for conception attempts. The hormonal cascade that triggers ovulation has been characterized with specific numerical thresholds that govern the fertile window.

• Ovulation is triggered when estrogen reaches 200 picograms and sustains for 50 hours, signaling the brain to release an LH surge
• The egg has only 24 hours to be fertilized after ovulation
• The fertile window comprises the 5 days before and the day of ovulation
• The two days before and day of ovulation carry a 20–30% chance of pregnancy per cycle
• The day after ovulation shows 0% chance of pregnancy
• Sperm can survive up to 5 days in the reproductive tract, though most survive approximately 2 days

IVF and Egg Freezing Facts

Common misconceptions about assisted reproductive technology deter有些人 from pursuing fertility preservation. The science demonstrates that egg freezing and IVF do not deplete ovarian reserve, making earlier intervention more efficient and cost-effective.

• IVF and egg freezing do not decrease ovarian reserve; they save eggs from a monthly cohort that would otherwise die
• Women constantly lose eggs regardless of activity—during pregnancy, breastfeeding, birth control, and before first period
• Freezing eggs at age 25 yields three times as many eggs as waiting until age 37
• IVF attrition rates: 90% of eggs survive freeze-thaw, 75% fertilize, 50% reach implantation stage (day 5–6)
• A genetically normal embryo has only a 65% chance of live birth
• If you have three genetically normal embryos, almost 95% of people will have a live birth
• The 60 days before pregnancy is when the egg is most susceptible to environmental influences ("trimester zero")

Birth Control and Preconception Planning

Different contraceptive methods have varying impacts on fertility return timelines. Understanding these timelines enables better preconception planning and prevents frustration when conception does not occur immediately after discontinuation.

• The birth control pill has a 28-hour half-life, meaning missing even one pill could result in ovulation
• Women prescribed the pill for irregular cycles or acne without a PCOS diagnosis often discover it was masking the condition
• Recommendation: Stop the pill 3–6 months before wanting to conceive to track cycles and identify any abnormalities early
• After progesterone IUD removal, endometrial receptivity is altered for at least 6 months with lower pregnancy rates in the first six months post-removal
• Depo-Provera, a high-dose intramuscular progesterone injection, can suppress ovulation for up to 18 months after a single dose
• Large studies show no higher rate of infertility after stopping any type of contraception compared to population baseline

Inflammation and Ovulation Requirements

A counterintuitive aspect of fertility biology involves the necessary role of acute inflammation in ovulation and implantation. Suppressing inflammation entirely can therefore be counterproductive for couples trying to conceive.

• Ovulation requires an acute inflammatory response to allow the follicle to rupture and release the egg
• The immune system is essential for both ovulation and implantation, making total immune suppression counterproductive for fertility
• NSAIDs (Advil, ibuprofen, Aleve) around the time of ovulation can prevent the follicle from rupturing and the egg from being released
• Women trying to conceive should only take NSAIDs during their period for cramping and avoid them for the rest of the cycle
• Cold plunges are similarly not recommended when trying to conceive because they inhibit acute inflammatory responses needed for ovulation
• Dr. Aimee's "five non-negotiables" for reducing inflammatory burden: sleep, stress, muscle, food, and toxins

Sleep's Impact on Fertility Outcomes

Sleep quality and duration affect fertility through hormonal mechanisms in both partners. The correlation between poor sleep and infertility represents a modifiable risk factor that couples can address through behavioral changes.

• Poor sleep doubles the rate of infertility and increases time to pregnancy for either partner
• Men who sleep less have lower testosterone levels and lower sperm counts
• Women who sleep less retrieve fewer eggs during IVF cycles
• Most women need approximately 7 to 8.5 hours of sleep
• 7.5 hours is especially important during the luteal phase when progesterone production demands significant metabolic resources
• Sleep optimization represents a non-invasive intervention that should precede more aggressive fertility treatments

Supplements for Fertility Optimization

Evidence-based supplementation can improve egg and sperm quality through mitochondrial health optimization and antioxidant mechanisms. Specific compounds have demonstrated efficacy in randomized controlled trials within IVF populations.

• CoQ10 has robust human data from randomized controlled trials in IVF subsets supporting egg and sperm quality through mitochondrial health optimization
• Melatonin at 1–3 milligrams taken 30 minutes before bed can improve egg quality and pregnancy odds
• Melatonin accumulates in the ovary during ovulation to counteract ovarian oxidative stress
• Melatonin is particularly beneficial for women with chronic inflammation, endometriosis, autoimmune disease, or poor egg quality
• Recommended 60 days before conception: prenatal vitamins with folic acid, CoQ10, omega-3 fatty acids, and vitamin D
• For sperm health: L-carnitine, zinc, and selenium are recommended
• NAD and NMN have only animal data supporting use for unexplained infertility

Cannabis, Nicotine, and Fertility Impacts

recreational substances including cannabis and nicotine have documented negative effects on both male and female fertility parameters. These effects persist even after discontinuation and should be addressed before conception attempts.

• Cannabis use affects sperm production, testosterone levels, and DNA fragmentation quality inside the sperm head
• When embryos halt at the male developmental stage on day three in IVF labs, 9 out of 10 times the male partner is using cannabis (often previously denied)
• Cannabis use in the prior year can decrease eggs retrieved by 25% and fertilization rates by 28%
• THC crosses the placenta directly, with THC levels highest in edibles
• Cigarette smoking decreases egg count, causes earlier menopause, and is detrimental to egg quality
• Oral nicotine pouches are significantly impacting sperm counts
• Nicotine, cannabis, and alcohol have no advantageous effects on fertility

Environmental Toxins and Endocrine Disruptors

Exposure to endocrine-disrupting chemicals correlates with worse IVF outcomes and reduced fertility across multiple population-based studies. Understanding common exposure sources enables practical avoidance strategies.

• IVF patients with higher levels of endocrine disrupting chemicals had fewer eggs retrieved, fewer embryos, and poorer sperm counts
• Lavender, tea tree oil, and evening primrose have endocrine-disrupting properties
• One of the top BPA exposures is thermal paper (receipts)
• Scented products contain phthalates; "unscented" means a scent was added to mask other scents while "fragrance-free" means no fragrance was added at all
• Frequent use of multiple low-level products matters more than one-time exposures for endocrine disruptors
• Microplastics accumulate inside the ovary and are detrimental to fertility
• Shauna Swan and the Environmental Working Group faced political backlash despite being data-focused, and their work on endocrine disruptors was initially dismissed as "hippie science"

GLP-1 Agonists and Endometriosis Connections

Many cases of unexplained infertility ultimately receive endometriosis diagnoses, highlighting the importance of considering this condition in differential diagnosis. GLP-1 agonists provide benefits for patients with endometriosis through weight loss and direct anti-inflammatory mechanisms.

• 50% of patients with unexplained infertility will end up having endometriosis
• The gold standard for endometriosis diagnosis is surgical only; no lab test exists
• GLP-1 agonists are widely accepted for PCOS and insulin resistance; weight loss can restore ovulation and improve IVF outcomes
• Fat cells make estrogen and are inflammatory, so weight loss addresses multiple fertility barriers simultaneously
• Low-dose GLP-1 use for 3 months followed by an IVF cycle produces more embryos in patients with known or probable endometriosis
• GLP-1 agonists provide direct anti-inflammatory effects independent of adipose tissue loss

Nutrition and Dietary Factors in Fertility

Dietary choices influence fertility through effects on inflammation, hormonal production, and metabolic function. Specific food categories and substitutions have documented impacts on ovulation and embryo development.

• For every serving of plant-based protein substituted for animal protein, people tended to ovulate better and had higher fertility rates
• Highest red meat exposure groups showed poorer embryo development, worse IVF outcomes, and increased staging of endometriosis at surgery
• Fiber is hugely important for gut microbiome, hormone health, inflammation, and insulin resistance
• Cholesterol is the backbone for steroid hormones; without sufficient saturated fat intake, the body cannot produce adequate progesterone for implantation
• Whole grain carbohydrates are preferred over refined carbohydrates in a fertility diet
• Ultra-processed foods, added artificial sugars, and non-nutritive sweeteners should not have a place in a fertility-supporting diet

The Medical System's Gatekeeping Problem

Standard medical definitions of infertility create barriers to early testing and intervention, potentially wasting critical months when biological windows are closing. The requirement that couples "fail" before receiving evaluation represents a systemic problem requiring advocacy.

• The standard medical definition of infertility requires 12 months of failed attempts before testing is recommended
• For women 35+, this interval shortens to 6 months
• Proactive testing could identify blocked fallopian tubes, uterine defects, azoospermia, or low ovarian reserve sooner
• Many patients are blocked by dismissive PCPs or OB/GYNs who tell them to just try first
• After two pregnancy losses, evaluation is needed including blood tests, semen analysis, sperm fragmentation, and uterine/tubal evaluation
• In recurrent pregnancy loss cases, approximately 80% of tests return normal results, but 20% reveal treatable conditions
• The top cause of pregnancy loss is random genetic abnormality—the embryo lacked the capacity to implant

Human Growth Hormone and Emerging Interventions

Human growth hormone has moved from skepticism to common use in fertility treatment over 15 years. Red light therapy represents an emerging intervention area targeting inflammation and mitochondrial function.

• Human growth hormone is used off-label for egg quality improvement when patients don't get enough mature eggs or embryos don't develop well
• HGH protocol involves approximately 2 IU nightly for about 2 weeks during stimulation
• HGH was considered scoff-worthy 15 years ago for fertility use; now it's commonly added when standard outcomes aren't achieved
• Sitting in front of a full-body red light panel is thought to decrease systemic inflammation, which may improve ovulatory patterns
• Studies are exploring ovarian-directed red light therapy, including vaginal ultrasound wands with integrated red light
• Proper chromosomal arrangement in eggs appears to be dependent on mitochondrial health, raising the hypothesis that red light exposure during egg fertilization could benefit embryo quality

Transcript: Download plain text